More Than £1.1million Of Funding To Support Cancer Research In Liverpool

Anne Jackson CEO North West cancer Research and Dr Jason Parsons
LIVERPOOL’S biggest funder of cancer research, North West Cancer Research, has announced it is to support £1.1milllion worth of new research projects over the next three years as part of its multi-million pound commitment to the fight against cancer. Cancer remains one of the biggest killers in Liverpool. Latest figures show that an average of 1300 people a year die from cancer and cancer- related illnesses. The number of new cancer cases diagnosed in Liverpool is higher than anywhere else in England. The good news is that for the first time ever, half of all people diagnosed with cancer now survive – news which charity North West Cancer Research believes is as a result of advances in cancer research. CEO Anne Jackson is encouraging people in Liverpool to help the charity to continue to support cancer research, and honour World Cancer Day by signing up to its flagship fundraiser event, Canter For Cancer. Participants in the event, which will include former Brookside actress Suzanne Collins, will wear novelty horse’s heads as they make their way around the 5k track at Aintree race course on Sunday March 6th. North West Cancer Research currently funds research across the North West, including projects totalling £7.7million at the University of Liverpool. It will now provide an additional £1,106,776 worth of funding to support a total of six new projects based in the city. It follows the first of two rounds of annual funding calls which the charity makes every year, inviting researchers from across the North West to submit grant applications to support research. Funded research projects, include those looking at therapeutic targets, basic cellular level research and those which will look more specifically at certain cancers including pancreatic cancer and skin cancer. The charity also awarded funding to a research project looking at improving our understanding of proton radiotherapy in the treatment of cancer. Liverpool is home to the UK’s only proton irradiator and is used for treating cancer of the eye. Proton therapy works by damaging DNA structure of cancerous cells, with minimal adverse effects on healthy cells. Based at the University of Liverpool, the project aims to increase our understanding of the effects of proton therapy on cancer cells in the hopes of developing more effective therapeutic targets. Ms Jackson said: “With our region having some of the highest incidences of cancer in the whole of the UK, it is critical that we continue to fund innovative and effective research, which looks to tackle the problem right here on our doorstep. “We recently announced that we would fund more than £11.2million of research over the next five years, but this latest round actually takes our commitment beyond the £12million mark. “The standard of grant submissions this year was exceptionally high and our Scientific Committee, which is made up of some of the country’s top cancer specialists, faced a serious challenge in selecting the strongest applications. “As a charity we pride ourselves on only backing the very highest standard of research, ensuring the best value for the support we provide. “We can only continue to fund the research we do with the help of our supporters, which is why fundraising events, such as Canter for Cancer are so important. With today being World Cancer Day it is the perfect opportunity for people sign up to the race and help us, help Liverpool say neigh to cancer once and for all.” Canter for Cancer is supported by The Liverpool FC Foundation, as well as Liverpool-based Investec Wealth & Investment which has been named as the headline sponsor.  More information and how to register can be found at www.canterforcancer.com